The interest slabs and rates for higher balance accounts remain unchanged
Overall equity capital market fundraising fell in 2025 due to weak follow-on and sell-down activity, even as IPO volumes touched a record high
Higher output at Jamshedpur and Kalinganagar drove Tata Steel India to its best-ever quarterly production and deliveries in Q3FY26
Inox Clean Energy ties up ₹3,100 crore equity from global and domestic investors to fund IPP growth and solar manufacturing expansion, valuing the firm at ₹50,000 crore
The news report further suggested that the CCI probe has also held 56 top executives liable for price collusion over varying periods between 2015 and 2023
Godrej Consumer Products expects double-digit consolidated revenue and EBITDA growth in the October-December quarter, led by strong home care demand and improving consumption trends
The company said Hevaxin is the only hepatitis E vaccine approved by the Drug Controller General of India (DCGI) and is indicated for active immunisation against HEV infection
The overall sDQI score for SCBs improved to 90.7 in September 2025, up from 89.9 in June 2025
Telecom revenues seen rising up to 2.6% in Q3FY26, led by Jio and Airtel, while Vodafone Idea lags amid subscriber losses and modest ARPU gains
In his new role, he will work closely with insurers, hospitals, regulators and other stakeholders to support sector-wide initiatives
Olympic javelin thrower Neeraj Chopra launches Vel Sports, his own athlete management firm, ending a decade-long association with JSW Sports
The capital raise reflects strong shareholder confidence in Avanse's strategy, governance, long-term growth potential, while reinforcing its disciplined approach to building a diversified funding base
Overall cargo in 2025 reached 99.17 million tonnes, up 9.86 per cent Y-o-Y
Mumbai accounted for 35 of the 51 ultra-luxury home deals in 2025, cornering over ₹5,100 crore in value, as India's wealthy continued to back big-ticket residential assets
Education Minister Dharmendra Pradhan says NCERT's transition will boost research and global collaboration as India shifts focus from degrees to skills-based education
Market regulator Sebi has given its observations for eight initial public offerings, including confidential filings by Indira IVF and Rays of Belief, paving the way for their proposed listings
Patent expiries of blockbuster weight-loss drug semaglutide may create a ₹5,000 crore generic opportunity for Indian pharma firms across India and key emerging and regulated markets
Campaign running from January 1 to March 2, 2026, allows revival of lapsed individual policies with concessions on late fees, aimed at restoring insurance cover for policyholders
Benchmark indices rose on Friday as optimism over December-quarter corporate earnings, rate cuts and tax rationalisation lifted sentiment, with Nifty and Sensex closing at record highs
Credit-infrastructure firm will use the funds to expand AI-driven risk and lending platforms and accelerate growth across the Middle East and Asia-Pacific regions